Filter by Category
Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Policy & Public
Food & Nutrition
Entrepreneurship
Energy & Environment
Emerging Technologies
Consumer Goods
Biomanufacturing, Chemicals & Materials
Funding & Investments
Health & Medicine
Agriculture
Subscribers Only
Access Ginkgo and Google Cloud Team Up to Supercharge Drug Development with New Protein LLM For Free!
Access Now
-

Ginkgo and Google Cloud Team Up to Supercharge Drug Development with New Protein LLM

September 16, 2024
Published
-
September 16, 2024
Subscribers Only
Access Peptone announces a collaboration with NVIDIA and Verne Global to scale its AI-driven protein engineering system For Free!
Access Now
digest
-

Peptone announces a collaboration with NVIDIA and Verne Global to scale its AI-driven protein engineering system

March 31, 2021
Published
-
March 31, 2021
Subscribers Only
Access Synthace More Than Doubles Its Annual Recurring Revenue; Expands Customer Footprint With the Top Pharma Companies In 2020 For Free!
Access Now
digest
-

Synthace More Than Doubles Its Annual Recurring Revenue; Expands Customer Footprint With the Top Pharma Companies In 2020

March 25, 2021
Published
-
March 25, 2021
Subscribers Only
Access TeselaGen Partners with Berkeley Lab’s Advanced Biofuels and Bioproducts Process Development Unit to Accelerate the Bioeconomy For Free!
Access Now
digest
-

TeselaGen Partners with Berkeley Lab’s Advanced Biofuels and Bioproducts Process Development Unit to Accelerate the Bioeconomy

March 19, 2021
Published
-
March 19, 2021
Subscribers Only
Access Molecular Assemblies to Provide Enzymatic Synthesis Technology to DARPA NOW Project for On-Demand DNA/RNA Vaccine Manufacturing For Free!
Access Now
digest
-

Molecular Assemblies to Provide Enzymatic Synthesis Technology to DARPA NOW Project for On-Demand DNA/RNA Vaccine Manufacturing

March 4, 2021
Published
-
March 4, 2021
Subscribers Only
Access DNA Script Joins GE Research Collaboration to Develop On-Demand Vaccines and Therapeutics in Response to Biothreats for DARPA NOW Project For Free!
Access Now
digest
-

DNA Script Joins GE Research Collaboration to Develop On-Demand Vaccines and Therapeutics in Response to Biothreats for DARPA NOW Project

March 3, 2021
Published
-
March 3, 2021
Subscribers Only
Access Twist Bioscience and Watchmaker Genomics Announce Partnership to Drive New Applications of High-throughput Genetic Sequencing For Free!
Access Now
digest
-

Twist Bioscience and Watchmaker Genomics Announce Partnership to Drive New Applications of High-throughput Genetic Sequencing

March 4, 2021
Published
-
March 4, 2021
Subscribers Only
Access Miroculus Closes Extension to $45M Series B Financing For Free!
Access Now
digest
-

Miroculus Closes Extension to $45M Series B Financing

March 1, 2021
Published
-
March 1, 2021
Subscribers Only
Access DNA Script Exclusively Licenses baseclick GmbH Technology to Enable Benchtop Printing of Modified DNA On-Demand For Free!
Access Now
digest
-

DNA Script Exclusively Licenses baseclick GmbH Technology to Enable Benchtop Printing of Modified DNA On-Demand

February 24, 2021
Published
-
February 24, 2021
Subscribers Only
Access Riffyn Doubles Customers and Recurring Revenue for Fourth Straight Year For Free!
Access Now
digest
-

Riffyn Doubles Customers and Recurring Revenue for Fourth Straight Year

February 20, 2021
Published
-
February 20, 2021
Subscribers Only
Access Excision BioTherapeutics Completes $60 Million Financing to Advance CRISPR-Based Infectious Disease Programs For Free!
Access Now
digest
-

Excision BioTherapeutics Completes $60 Million Financing to Advance CRISPR-Based Infectious Disease Programs

February 18, 2021
Published
-
February 18, 2021
Subscribers Only
Access SPT Labtech acquires BioMicroLab For Free!
Access Now
digest
-

SPT Labtech acquires BioMicroLab

February 18, 2021
Published
-
February 18, 2021
Subscribers Only
Access ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement For Free!
Access Now
digest
-

ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement

February 17, 2021
Published
-
February 17, 2021
Subscribers Only
Access Codexis Announces Expansion to New Facility to Accommodate Next Stage of Growth For Free!
Access Now
digest
-

Codexis Announces Expansion to New Facility to Accommodate Next Stage of Growth

February 11, 2021
Published
-
February 11, 2021
Subscribers Only
Access Berkeley Lights Announces CFO Transition and C-Level Additions For Free!
Access Now
digest
-

Berkeley Lights Announces CFO Transition and C-Level Additions

February 8, 2021
Published
-
February 8, 2021
Subscribers Only
Access Codexis Appoints Dr. Esther Martinborough to its Board of Directors For Free!
Access Now
digest
-

Codexis Appoints Dr. Esther Martinborough to its Board of Directors

February 5, 2021
Published
-
February 5, 2021
Subscribers Only
Access Twist Bioscience Announces Executive Team Appointments For Free!
Access Now
digest
-

Twist Bioscience Announces Executive Team Appointments

February 4, 2021
Published
-
February 4, 2021
Subscribers Only
Access Evozyne Announces a Strategic Collaboration for Development of Novel Biopharmaceutical Therapeutics For Free!
Access Now
digest
-

Evozyne Announces a Strategic Collaboration for Development of Novel Biopharmaceutical Therapeutics

February 3, 2021
Published
-
February 3, 2021
Subscribers Only
Access DNA Script Signs Innovation Development Contract With French Defence Innovation Agency to Enable On-Demand Diagnostics Against Emerging Biothreats For Free!
Access Now
digest
-

DNA Script Signs Innovation Development Contract With French Defence Innovation Agency to Enable On-Demand Diagnostics Against Emerging Biothreats

January 29, 2021
Published
-
January 29, 2021
Subscribers Only
Access Biotech Startup Droplet Genomics Raises €1 Million from Practica Capital to Commercialize Droplet Microfluidics Technology For Free!
Access Now
digest
-

Biotech Startup Droplet Genomics Raises €1 Million from Practica Capital to Commercialize Droplet Microfluidics Technology

January 28, 2021
Published
-
January 28, 2021
Subscribers Only
Access Verve Therapeutics Secures $94 Million in Series B Financing to Advance Pipeline of Gene Editing Medicines for Cardiovascular Disease For Free!
Access Now
digest
-

Verve Therapeutics Secures $94 Million in Series B Financing to Advance Pipeline of Gene Editing Medicines for Cardiovascular Disease

January 25, 2021
Published
-
January 25, 2021
Cookie Policy

Lorem ipsum dolor sit amet, consectetur adip elit. Donec posuere dolor massa, pellentesque aliquam nisl facilisis sed.

ManageAccept
Copyright SynBioBeta 2024